APA (7th ed.) Citation

JS, P., OW, F., CC, W., J, M., & E, H. (2026). Pembrolizumab-associated hemophagocytic lymphohistiocytosis in recurrent metastatic squamous cell carcinoma of the ovary arising in a teratoma. Gynecologic oncology reports, 64, 102059. https://doi.org/10.1016/j.gore.2026.102059

Chicago Style (17th ed.) Citation

JS, Powers, Foley OW, Wang CC, Marcus J, and Hinchcliff E. "Pembrolizumab-associated Hemophagocytic Lymphohistiocytosis in Recurrent Metastatic Squamous Cell Carcinoma of the Ovary Arising in a Teratoma." Gynecologic Oncology Reports 64 (2026): 102059. https://doi.org/10.1016/j.gore.2026.102059.

MLA (9th ed.) Citation

JS, Powers, et al. "Pembrolizumab-associated Hemophagocytic Lymphohistiocytosis in Recurrent Metastatic Squamous Cell Carcinoma of the Ovary Arising in a Teratoma." Gynecologic Oncology Reports, vol. 64, 2026, p. 102059, https://doi.org/10.1016/j.gore.2026.102059.